Ontario Clinical Oncology Group (OCOG)
65
6
10
48
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
7.7%
5 terminated/withdrawn out of 65 trials
90.6%
+4.1% vs industry average
35%
23 trials in Phase 3/4
4%
2 of 48 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (65)
Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma
Role: lead
A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)
Role: lead
Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC)
Role: lead
Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)
Role: collaborator
Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy
Role: lead
Hypofractionated LocoRegional Radiotherapy in Breast Cancer
Role: lead
Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)
Role: lead
SBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney Cancer
Role: lead
A Prospective Cohort Study Evaluating Risk of Local Recurrence Following Breast Conserving Surgery and Endocrine Therapy in Low Risk Luminal A Breast Cancer
Role: lead
Neoadjuvant Combination of Atezolizumab/Bevacizumab Versus Neoadjuvant Radiation Therapy
Role: lead
Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging
Role: lead
Infection Prophylaxis in Total Joint Replacement
Role: collaborator
Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)
Role: lead
Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer
Role: lead
Trial of Radiation Fractionation Schedules for Once-a-Day Accelerated Partial Breast Irradiation
Role: lead
Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients
Role: lead
Assessment of New Molecular Imaging Strategies for Prostate Cancer
Role: lead
Investigation of the Anti-Cancer Activity of Artichoke Extract in an Asbestos-Exposed Population
Role: lead
Randomized Trial of eOncoNote
Role: collaborator
A Pragmatic Trial of Ambulatory Toxicity Management in Patients Receiving Adjuvant or Neo-adjuvant Chemotherapy for Early Stage Breast Cancer
Role: lead